Baishan Jiang

3.0k total citations · 1 hit paper
29 papers, 1.5k citations indexed

About

Baishan Jiang is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Baishan Jiang has authored 29 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 12 papers in Oncology and 5 papers in Organic Chemistry. Recurrent topics in Baishan Jiang's work include Protein Degradation and Inhibitors (11 papers), Ubiquitin and proteasome pathways (6 papers) and Peptidase Inhibition and Analysis (5 papers). Baishan Jiang is often cited by papers focused on Protein Degradation and Inhibitors (11 papers), Ubiquitin and proteasome pathways (6 papers) and Peptidase Inhibition and Analysis (5 papers). Baishan Jiang collaborates with scholars based in United States, China and Germany. Baishan Jiang's co-authors include Nathanael S. Gray, Tinghu Zhang, Eric S. Fischer, Yanke Liang, Nicholas Kwiatkowski, Katherine A. Donovan, Eric S. Wang, Georg Winter, James E. Bradner and Zainab M. Doctor and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Journal of Clinical Investigation.

In The Last Decade

Baishan Jiang

29 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pharmacological perturbation of CDK9 using selective CDK9 inhibition or degradation

2017 402 citations Baishan Jiang, Michael A. Erb et al. Nature Chemical Biology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Baishan Jiang United States	15	1.2k	541	227	170	136	29	1.5k
Georg Winter United States	12	1.8k 1.5×	589 1.1×	300 1.3×	107 0.6×	63 0.5×	20	2.0k
Taavi K. Neklesa United States	18	2.0k 1.7×	784 1.4×	380 1.7×	221 1.3×	141 1.0×	25	2.2k
Hongliang Zong China	20	708 0.6×	259 0.5×	126 0.6×	139 0.8×	69 0.5×	34	1.1k
Berkley E. Gryder United States	21	1.2k 1.0×	545 1.0×	86 0.4×	228 1.3×	198 1.5×	48	1.8k
Daniel P. Bondeson United States	8	1.4k 1.2×	621 1.1×	448 2.0×	62 0.4×	68 0.5×	10	1.6k
Jimmy A. Blair United States	12	1.0k 0.9×	812 1.5×	53 0.2×	253 1.5×	169 1.2×	16	1.7k
Claire Bonfils Canada	12	956 0.8×	287 0.5×	111 0.5×	38 0.2×	93 0.7×	25	1.1k
Kanak Raina United States	14	2.8k 2.4×	996 1.8×	828 3.6×	88 0.5×	166 1.2×	23	3.0k
Hyun Seop Tae United States	15	1.9k 1.6×	765 1.4×	332 1.5×	89 0.5×	220 1.6×	20	2.1k
Caroline B. Ho United States	10	1.6k 1.3×	405 0.7×	65 0.3×	68 0.4×	167 1.2×	15	1.9k

Countries citing papers authored by Baishan Jiang

Since Specialization

Citations

This map shows the geographic impact of Baishan Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Baishan Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Baishan Jiang more than expected).

Fields of papers citing papers by Baishan Jiang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Baishan Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Baishan Jiang. The network helps show where Baishan Jiang may publish in the future.

Co-authorship network of co-authors of Baishan Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Baishan Jiang. A scholar is included among the top collaborators of Baishan Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Baishan Jiang. Baishan Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gui, Fu, Baishan Jiang, Jie Jiang, et al.. (2025). Acute BRCAness induction and AR pathway blockage through CDK12/7/9 degradation enhances PARP inhibitor sensitivity in prostate cancer. Science Advances. 11(17). eadu0847–eadu0847. 2 indexed citations

Chen, Lu, Lu Huang, Yuanyuan Wu, et al.. (2025). Selective and Potent Molecular Glue Degraders for NIMA‐Related Kinase 7. Angewandte Chemie International Edition. 64(12). e202500169–e202500169. 5 indexed citations

Chen, Lu, Lu Huang, Yuanyuan Wu, et al.. (2025). Selective and Potent Molecular Glue Degraders for NIMA‐Related Kinase 7. Angewandte Chemie. 137(12). 2 indexed citations

Chen, Lü, Xiaozhong Peng, Lixin Zhou, et al.. (2024). Development of Oral, Potent, and Selective CK1α Degraders for AML Therapy. SHILAP Revista de lepidopterología. 4(11). 4423–4434. 4 indexed citations

Zhou, Yaru, Shaowei Wang, Ming Gao, et al.. (2024). Palmitoylation of KSHV pORF55 is required for Golgi localization and efficient progeny virion production. PLoS Pathogens. 20(4). e1012141–e1012141. 7 indexed citations

Gao, Xueliang, Yongxia Wu, Joel M. Chick, et al.. (2023). Targeting protein tyrosine phosphatases for CDK6-induced immunotherapy resistance. Cell Reports. 42(4). 112314–112314. 6 indexed citations

Doctor, Zainab M., Annan Yang, Mingfeng Hao, et al.. (2023). Development and Characterization of Selective FAK Inhibitors and PROTACs with In Vivo Activity. ChemBioChem. 24(19). e202300141–e202300141. 8 indexed citations

Jiang, Baishan, David M. Weinstock, Katherine A. Donovan, et al.. (2023). ITK degradation to block T cell receptor signaling and overcome therapeutic resistance in T cell lymphomas. Cell chemical biology. 30(4). 383–393.e6. 8 indexed citations

Kumarasamy, Vishnu, Baishan Jiang, Seth M. Rubin, et al.. (2023). PROTAC-mediated CDK degradation differentially impacts cancer cell cycles due to heterogeneity in kinase dependencies. British Journal of Cancer. 129(8). 1238–1250. 11 indexed citations

10.

Jiang, Baishan, Yang Gao, Jianwei Che, et al.. (2021). Discovery and resistance mechanism of a selective CDK12 degrader. Nature Chemical Biology. 17(6). 675–683. 96 indexed citations

11.

Jiang, Baishan, Jie Jiang, Ines H. Kaltheuner, et al.. (2021). Structure-activity relationship study of THZ531 derivatives enables the discovery of BSJ-01-175 as a dual CDK12/13 covalent inhibitor with efficacy in Ewing sarcoma. European Journal of Medicinal Chemistry. 221. 113481–113481. 41 indexed citations

12.

Gao, Xueliang, Yongxia Wu, Chen Chu, et al.. (2021). Nuclear PFKP promotes CXCR4-dependent infiltration by T cell acute lymphoblastic leukemia. Journal of Clinical Investigation. 131(16). 28 indexed citations

13.

Jiang, Jie, Baishan Jiang, Zhixiang He, et al.. (2020). Discovery of Covalent MKK4/7 Dual Inhibitor. Cell chemical biology. 27(12). 1553–1560.e8. 14 indexed citations

14.

Sun, Ning, Dou Wang, Xiaomei Li, et al.. (2019). <p>pH-dependent and cathepsin B activable CaCO<sub>3</sub> nanoprobe for targeted in vivo tumor imaging</p>. International Journal of Nanomedicine. Volume 14. 4309–4317. 9 indexed citations

15.

Brand, Matthias, Baishan Jiang, Sophie Bauer, et al.. (2018). Homolog-Selective Degradation as a Strategy to Probe the Function of CDK6 in AML. Cell chemical biology. 26(2). 300–306.e9. 195 indexed citations

16.

Browne, Christopher M., Baishan Jiang, Scott B. Ficarro, et al.. (2018). A Chemoproteomic Strategy for Direct and Proteome-Wide Covalent Inhibitor Target-Site Identification. Journal of the American Chemical Society. 141(1). 191–203. 56 indexed citations

17.

Jiang, Baishan, Michael A. Erb, Yanke Liang, et al.. (2017). Pharmacological perturbation of CDK9 using selective CDK9 inhibition or degradation. DSpace@MIT (Massachusetts Institute of Technology). 1 indexed citations

18.

Jiang, Baishan, Michael A. Erb, Yanke Liang, et al.. (2017). Pharmacological perturbation of CDK9 using selective CDK9 inhibition or degradation. Nature Chemical Biology. 14(2). 163–170. 402 indexed citations breakdown →

19.

Johannessen, Liv, Thomas B. Sundberg, Daniel J. O’Connell, et al.. (2017). Small-molecule studies identify CDK8 as a regulator of IL-10 in myeloid cells. Nature Chemical Biology. 13(10). 1102–1108. 46 indexed citations

20.

Fang, Zhiyuan, et al.. (2013). ELISA detection of semicarbazide based on a fast sample pretreatment method. Chemical Communications. 49(55). 6164–6164. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact